Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen

55Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen. Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Polley, R., Stager, S., Prickett, S., Maroof, A., Zubairi, S., Smith, D. F., & Kaye, P. M. (2006). Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infection and Immunity, 74(1), 773–776. https://doi.org/10.1128/IAI.74.1.773-776.2006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free